Gemma Hayes

452 total citations
11 papers, 240 citations indexed

About

Gemma Hayes is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gemma Hayes has authored 11 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gemma Hayes's work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (5 papers) and Asthma and respiratory diseases (4 papers). Gemma Hayes is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (5 papers) and Asthma and respiratory diseases (4 papers). Gemma Hayes collaborates with scholars based in United Kingdom and Israel. Gemma Hayes's co-authors include David W. Denning, Lilyann Novak Frazer, Chris Harris, Chris Kosmidis, Elaine Bignell, Margherita Bertuzzi, Felix Bongomin, Norman van Rhijn, Nir Osherov and Edward J M Monk and has published in prestigious journals such as PLoS ONE, FEMS Microbiology Reviews and Thorax.

In The Last Decade

Gemma Hayes

11 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Hayes United Kingdom 7 191 164 91 49 20 11 240
Shotaro Ide Japan 8 180 0.9× 179 1.1× 76 0.8× 74 1.5× 19 0.9× 35 288
AO Soubani United States 5 243 1.3× 199 1.2× 138 1.5× 49 1.0× 20 1.0× 5 347
Arunaloke Chakrabarti India 8 207 1.1× 125 0.8× 43 0.5× 71 1.4× 19 0.9× 21 306
Findra Setianingrum Indonesia 9 283 1.5× 270 1.6× 55 0.6× 42 0.9× 27 1.4× 17 354
Pete Strong Japan 9 188 1.0× 174 1.1× 75 0.8× 14 0.3× 11 0.6× 19 258
Tomo Mihara Japan 9 253 1.3× 204 1.2× 57 0.6× 38 0.8× 30 1.5× 13 298
Marie Kirwan United Kingdom 6 276 1.4× 199 1.2× 119 1.3× 62 1.3× 55 2.8× 7 352
Sven Heldt Austria 9 353 1.8× 332 2.0× 66 0.7× 79 1.6× 54 2.7× 12 389
Giel R. Gaajetaan Netherlands 7 225 1.2× 243 1.5× 34 0.4× 47 1.0× 86 4.3× 11 304
Irina Vennewald Germany 7 149 0.8× 144 0.9× 41 0.5× 98 2.0× 47 2.4× 12 309

Countries citing papers authored by Gemma Hayes

Since Specialization
Citations

This map shows the geographic impact of Gemma Hayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Hayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Hayes more than expected).

Fields of papers citing papers by Gemma Hayes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Hayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Hayes. The network helps show where Gemma Hayes may publish in the future.

Co-authorship network of co-authors of Gemma Hayes

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Hayes. A scholar is included among the top collaborators of Gemma Hayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Hayes. Gemma Hayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hyland, Michael E., Andrew Menzies‐Gow, Adel Mansur, et al.. (2021). Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma. Chronic Respiratory Disease. 18. 4053467850–4053467850. 6 indexed citations
2.
Jones, Rupert, Michael E. Hyland, Andrew Menzies‐Gow, et al.. (2020). Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ. 2241–2241. 2 indexed citations
3.
Monk, Edward J M, Chris Harris, Rainer Döffinger, et al.. (2020). Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission. Thorax. 75(6). 513–516. 14 indexed citations
4.
Jones, Rupert, Michael E. Hyland, Andrew Menzies‐Gow, et al.. (2020). Quality of life in severe asthma measured by SAQ and EQ5D questionnaires as a function of clinically relevant cut off points. 2249–2249. 1 indexed citations
5.
Bertuzzi, Margherita, Gemma Hayes, & Elaine Bignell. (2019). Microbial uptake by the respiratory epithelium: outcomes for host and pathogen. FEMS Microbiology Reviews. 43(2). 145–161. 21 indexed citations
6.
Bongomin, Felix, Chris Harris, Gemma Hayes, Chris Kosmidis, & David W. Denning. (2018). Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS ONE. 13(4). e0193732–e0193732. 67 indexed citations
7.
Bertuzzi, Margherita, Gemma Hayes, Norman van Rhijn, et al.. (2018). Anti-Aspergillus Activities of the Respiratory Epithelium in Health and Disease. Journal of Fungi. 4(1). 8–8. 42 indexed citations
8.
Gamaletsou, Maria N., et al.. (2017). F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis. Journal of Asthma. 55(8). 837–843. 6 indexed citations
9.
Hayes, Gemma & Lilyann Novak Frazer. (2016). Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?. Journal of Fungi. 2(2). 18–18. 50 indexed citations
10.
Hayes, Gemma & David W. Denning. (2013). Frequency, diagnosis and management of fungal respiratory infections. Current Opinion in Pulmonary Medicine. 19(3). 259–265. 30 indexed citations
11.
Hayes, Gemma, Matthew Masoli, Ben Whalley, Rupert Jones, & Michael E. Hyland. (2013). S91 Fungal sensitisation and bronchiectasis in a severe asthma clinic. Thorax. 68(Suppl 3). A49.1–A49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026